Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for treating nerve damage rather than only suppressing inflammation. Multiple sclerosis (MS) is one of the leading causes of neurological disability in young adults, affecting nearly three million people worldwide. Despite decades of research and major advances in [...]